Article
HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer
20 Dec 2017
Abstract excerpt
HSPA5/GRP78/BiP plays an important role in cell survival or tumor progression. For these reasons, HSPA5 is an emerging therapeutic target in cancer development. Here we report that HSPA5 contributes to head and neck cancer (HNC) survival via maintenance of lysosomal activity; however, a nonthermal plasma (NTP, considered as a next-generation cancer therapy)-treated solution (NTS) inhibits HNC progression through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
